SFB 432: Mechanismen der Tumorabwehr und ihre therapeutische Beeinflussung
Forschungsverbund / Johannes Gutenberg-Universität Mainz
Erlach, KC; Bohm, V; Knabe, M et al.
Activation of hepatic natural killer cells and control of liver-adapted lymphoma in the murine model of cytomegalovirus infection.Med Microbiol Immunol. Bd. 197. H. 2. 2008 S. 167-78
Distler, E; Wolfel, C; Kohler, S et al.
Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.Exp Hematol. Bd. 36. H. 4. 2008 S. 451-63
Holtappels, R; Bohm, V; Podlech, J et al.
CD8 T-cell-based immunotherapy of cytomegalovirus infection: "proof of concept" provided by the murine model.Med Microbiol Immunol. Bd. 197. H. 2. 2008 S. 125-34
Sahin, U; Koslowski, M; Dhaene, K et al.
Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development.Clin Cancer Res. Bd. 14. H. 23. 2008 S. 7624-34
Wolfel, C; Lennerz, V; Lindemann, E et al.
Dissection and molecular analysis of alloreactive CD8+ T cell responses in allogeneic haematopoietic stem cell transplantation.Cancer Immunol Immunother. Bd. 57. H. 6. 2008 S. 849-57
Cicin-Sain, L; Ruzsics, Z; Podlech, J et al.
Dominant-negative FADD rescues the in vivo fitness of a cytomegalovirus lacking an antiapoptotic viral gene.J Virol. Bd. 82. H. 5. 2008 S. 2056-64
Bohm, V; Podlech, J; Thomas, D et al.
Epitope-specific in vivo protection against cytomegalovirus disease by CD8 T cells in the murine model of preemptive immunotherapy.Med Microbiol Immunol. Bd. 197. H. 2. 2008 S. 135-44
Tschiedel, S; Gentilini, C; Lange, T et al.
Identification of NM23-H2 as a tumour-associated antigen in chronic myeloid leukaemia.Leukemia. Bd. 22. H. 8. 2008 S. 1542-50
Javorovic, M; Wilde, S; Zobywalski, A et al.
Inhibitory effect of RNA pool complexity on stimulatory capacity of RNA-pulsed dendritic cells.J Immunother. Bd. 31. H. 1. 2008 S. 52-62
Wirtz, N; Schader, SI; Holtappels, R et al.
Polyclonal cytomegalovirus-specific antibodies not only prevent virus dissemination from the portal of entry but also inhibit focal virus spread within target tissues.Med Microbiol Immunol. Bd. 197. H. 2. 2008 S. 151-8
Holtappels, R; Simon, CO; Munks, MW et al.
Subdominant CD8 T-cell epitopes account for protection against cytomegalovirus independent of immunodomination.J Virol. Bd. 82. H. 12. 2008 S. 5781-96
Hahnel, PS; Thaler, S; Antunes, E et al.
Targeting AKT signaling sensitizes cancer to cellular immunotherapy.Cancer Res. Bd. 68. H. 10. 2008 S. 3899-906
Sacher, T; Podlech, J; Mohr, CA et al.
The major virus-producing cell type during murine cytomegalovirus infection, the hepatocyte, is not the source of virus dissemination in the host.Cell Host Microbe. Bd. 3. H. 4. 2008 S. 263-72
Graf, C; Heidel, F; Tenzer, S et al.
A neoepitope generated by an FLT3 internal tandem duplication (FLT3-ITD) is recognized by leukemia-reactive autologous CD8+ T cells.Blood. Bd. 109. H. 7. 2007 S. 2985-8
Koslowski, M; Sahin, U; Mitnacht-Kraus, R et al.
A placenta-specific gene ectopically activated in many human cancers is essentially involved in malignant cell processes.Cancer Res. Bd. 67. H. 19. 2007 S. 9528-34
Roos, WP; Batista, LFZ; Naumann, S et al.
Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanineOncogene. Bd. 26. 2007 S. 186-197
Kuball, J; Dossett, ML; Wolfl, M et al.
Facilitating matched pairing and expression of TCR chains introduced into human T cells.Blood. Bd. 109. H. 6. 2007 S. 2331-8
Briegert, M; Kaina, B
Human monocytes, but not dendritic cells derived from them, are defective in base excision repair and hypersensitive to methylating agentsCancer Res. Bd. 67. 2007 S. 26-31
Tuettenberg, A; Koelsch, S; Knop, J et al.
Oxymetazoline modulates proinflammatory cytokines and the T-cell stimulatory capacity of dendritic cells.Exp Dermatol. Bd. 16. 2007 S. 171-178
Besold, K; Frankenberg, N; Pepperl-Klindworth, S et al.
Processing and MHC class I presentation of human cytomegalovirus pp65-derived peptides persist despite gpUS2-11-mediated immune evasionJ Gen Virol. Bd. 88. 2007 S. 1429-1439
Meyer, RG; Britten, CM; Wehler, D et al.
Prophylactic transfer of CD8-depleted donor lymphocytes after T-cell-depleted reduced-intensity transplantation.Blood. Bd. 109. H. 1. 2007 S. 374-82
Meyer, RG; Graf, C; Britten, CM et al.
Rapid identification of an HLA-B*1501-restricted vaccinia peptide antigen.Vaccine. Bd. 25. H. 24. 2007 S. 4715-22
Cornelissen, JJ; van Putten, WL; Verdonck, LF et al.
Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?Blood. Bd. 109. H. 9. 2007 S. 3658-66
Kreiter, S; Konrad, T; Sester, M et al.
Simultaneous ex vivo quantification of antigen-specific CD4+ and CD8+ T cell responses using in vitro transcribed RNA.Cancer Immunol Immunother. Bd. 56. H. 10. 2007 S. 1577-87
Wehler, TC; Nonn, M; Brandt, B et al.
Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines.Blood. Bd. 109. H. 1. 2007 S. 365-73